NASDAQ:TLRY (Tilray)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Tilray (NASDAQ: TLRY) Latest News

Cannabis Stocks
Why Marijuana Stocks are Dropping Like a Rock!

Cannabis Stocks
Should You Invest in Marijuana Stock IPOs?

Cannabis Stocks
The 2 Worst-Performing Marijuana Stocks of 2019 (So Far)

Cannabis Stocks
3 Tanking Marijuana Stocks That Still Aren’t Worth Buying

Cannabis Stocks
TFSA Investors: Should You Own Marijuana Stocks?

Cannabis Stocks
3 Marijuana Stocks to Sell in September

Cannabis Stocks
Tilray (NASDAQ:TLRY): The Fall of a Weed Stock

Cannabis Stocks
Why a Bloodbath in Top Marijuana Stocks Is a Buying Opportunity

Stocks for Beginners
These Canadian Cannabis Stocks Are High-Risk Investments Right Now

Cannabis Stocks
Tilray (NASDAQ:TLRY) vs. Aphria (TSX:APHA): Which Marijuana Stock Is Riskier?

Cannabis Stocks
WARNING: These 2 Marijuana Stocks Could Collapse in the Second Half of 2019
